| Date | Title | Description | |
|---|---|---|---|
| 02 Apr 2024 | On business and financial situation | ROVI informs on the FDA’s approval of Risvan® as a treatment for schizophrenia | Download |
| 29 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 22 March and 27 March 2024 | Download |
| 22 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 15 March and 21 March 2024 | Download |
| 15 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 8 March and 14 March 2024 | Download |
| 12 Mar 2024 | On business and financial situation | ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 24 Feb 2016 | Informe anual de remuneraciones de los consejeros 2015 | ROVI releases the 2015 annual report regarding remuneration of the members of the Board of Directors | Download |
| 23 Dec 2015 | Otros sobre operaciones corporativas | Download | |
| 21 Dec 2015 | Otros sobre operaciones corporativas | Download | |
| 01 Dec 2015 | Otros sobre gobierno corporativo | Download | |
| 01 Dec 2015 | Otros sobre Gobierno Corporativo (2) | Download |